Raymond Cohen is the founder of Axonics Modulation Technologies. Axonics Modulation Technologies has raised $59M in total funding. Latest round: Series B.
Raymond Cohen is the CEO of Axonics Modulation Technologies, a California startup developing miniaturized implantable neuromodulation technology to treat conditions like chronic pain and overactive bladder. The company has raised $59 million in capital, including a $32.6 million Series A and a $38.5 million Series B. Cohen previously served as CEO of Vessix Vascular, which was acquired by Boston Scientific in 2012.
Full founder directory · Investor directory · Company funding database · Fundraising library